Nicotine therapeutic benefits: Difference between revisions
| Line 1,282: | Line 1,282: | ||
='''Pyoderma Gangrenosum'''= | ='''Pyoderma Gangrenosum'''= | ||
===2004 [https://pubmed.ncbi.nlm.nih.gov/15204166/ Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream]=== | ===2004 [https://pubmed.ncbi.nlm.nih.gov/15204166/ Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream]=== | ||
*Two patients with pyoderma gangrenosum treated with topical nicotine 0.5% w/w cetamacrogol formula A cream are described here, both of whom had dramatic clinical resolution of their pyoderma gangrenosum. | *Two patients with pyoderma gangrenosum treated with topical nicotine 0.5% w/w cetamacrogol formula A cream are described here, both of whom had dramatic clinical resolution of their pyoderma gangrenosum. | ||
*[https://scihubtw.tw/10.1080/09546630310019364 PDF Version] | *[https://scihubtw.tw/10.1080/09546630310019364 PDF Version] | ||
*Citations:Patel GK, Rhodes JR, Evans B, Holt PJ. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream. J Dermatolog Treat. 2004 Apr;15(2):122-5. doi: 10.1080/09546630310019364. PMID: 15204166. | **Citations:Patel GK, Rhodes JR, Evans B, Holt PJ. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream. J Dermatolog Treat. 2004 Apr;15(2):122-5. doi: 10.1080/09546630310019364. PMID: 15204166. | ||
===1998 [https://jamanetwork.com/journals/jamadermatology/fullarticle/189304?fbclid=IwAR33gpEktRMf2Q0v5Btl9C5E8gmXw-ZP8_gDFt6sebxUBpXE_WfVt-o-mSw Nicotine for Pyoderma Gangrenosum]=== | ===1998 [https://jamanetwork.com/journals/jamadermatology/fullarticle/189304?fbclid=IwAR33gpEktRMf2Q0v5Btl9C5E8gmXw-ZP8_gDFt6sebxUBpXE_WfVt-o-mSw Nicotine for Pyoderma Gangrenosum]=== | ||
*Herein we describe a patient with pyoderma gangrenosum who responded twice to topical nicotine within 4 weeks and 3 months, respectively, without any adverse effects. | *Herein we describe a patient with pyoderma gangrenosum who responded twice to topical nicotine within 4 weeks and 3 months, respectively, without any adverse effects. | ||
*[https://scholar.google.com/scholar_url?url=https://jamanetwork.com/journals/jamadermatology/articlepdf/189304/dce8005.pdf&hl=en&sa=T&oi=ucasa&ct=ufr&ei=Z2aqX4SnOc2rywTPj5aYDw&scisig=AAGBfm1pz6ffl3a23G__I3APgBLpY6Cofw PDF Version] | *[https://scholar.google.com/scholar_url?url=https://jamanetwork.com/journals/jamadermatology/articlepdf/189304/dce8005.pdf&hl=en&sa=T&oi=ucasa&ct=ufr&ei=Z2aqX4SnOc2rywTPj5aYDw&scisig=AAGBfm1pz6ffl3a23G__I3APgBLpY6Cofw PDF Version] | ||
*Citation: Wolf R, Ruocco V. Nicotine for Pyoderma Gangrenosum. Arch Dermatol. 1998;134(9):1071–1072. doi:10.1001/archderm.134.9.1071 | **Citation: Wolf R, Ruocco V. Nicotine for Pyoderma Gangrenosum. Arch Dermatol. 1998;134(9):1071–1072. doi:10.1001/archderm.134.9.1071 | ||
===1995 [https://pubmed.ncbi.nlm.nih.gov/8537562/ Successful treatment of pyoderma gangrenosum with nicotine chewing gum]=== | ===1995 [https://pubmed.ncbi.nlm.nih.gov/8537562/ Successful treatment of pyoderma gangrenosum with nicotine chewing gum]=== | ||
*We used nicotine chewing gum for the treatment of pyoderma gangrenosum with remarkable results. We strongly suggest that nicotine chewing gum may not only be beneficial in treating pyoderma gangrenosum but may also be useful in treating other skin disorders with prominent neutrophilic infiltrations such as Behcet's disease, Sweet disease, allergic vasculitis, and recurrent oral aphthae, the last of which is known to respond to smoking. | *We used nicotine chewing gum for the treatment of pyoderma gangrenosum with remarkable results. We strongly suggest that nicotine chewing gum may not only be beneficial in treating pyoderma gangrenosum but may also be useful in treating other skin disorders with prominent neutrophilic infiltrations such as Behcet's disease, Sweet disease, allergic vasculitis, and recurrent oral aphthae, the last of which is known to respond to smoking. | ||
*[https://sci-hub.st/10.1111/j.1346-8138.1995.tb03904.x PDF Version] | *[https://sci-hub.st/10.1111/j.1346-8138.1995.tb03904.x PDF Version] | ||
*Citation: Kanekura T, Kanzaki T. Successful treatment of pyoderma gangrenosum with nicotine chewing gum. J Dermatol. 1995 Sep;22(9):704-5. doi: 10.1111/j.1346-8138.1995.tb03904.x. PMID: 8537562. | **Citation: Kanekura T, Kanzaki T. Successful treatment of pyoderma gangrenosum with nicotine chewing gum. J Dermatol. 1995 Sep;22(9):704-5. doi: 10.1111/j.1346-8138.1995.tb03904.x. PMID: 8537562. | ||
<br> | <br> | ||